However, biomarkers that have been evaluated for their diagnostic performance in predicting gastric cancer stage are scarce, highlighting the advantage of serum G6PD levels as a potential tool to screen for disease progression in gastric cancer patients. Here, G6PD is linked to gastric cancer.